Impact of beta-lactam allergy labels on bone marrow transplant patients
We did not observe a significant increased risk of mortality in BMT patients with beta-lactam allergy labels; however, increased carbapenem use was observed. Penicillin allergy de-labeling programs may help optimize antibiotic prescribing in BMT patients. Larger studies are needed to quantify the impact of beta-lactam allergy labels on BMT patient outcomes.
Authors
- Caitlin M. McCracken (ORCID: https://orcid.org/0000-0003-3234-3860)
- Jessina C. McGregor (ORCID: https://orcid.org/0000-0002-6093-5444)
- Kendall J Tucker (ORCID: https://orcid.org/0000-0001-5868-0449)
- Jon P. Furuno (ORCID: https://orcid.org/0000-0002-8853-5733)
- Young Yoon Ham (ORCID: https://orcid.org/0000-0002-5644-4896)
- Benjamin M Haxby
Institutions
- Oregon State University (US)
- Oregon Health & Science University (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.172
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.39